First New York Securities’s THERAGENICS CORP TGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-3,200
Closed -$6K 492
2013
Q3
$6K Buy
+3,200
New +$6.82K ﹤0.01% 337

First New York Securities's TGX Position: Q4 2013 in Review

First New York Securities sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 3,200 shares — an estimated $6K sold.

First New York Securities first reported a position in TGX in Q3 2013 and held it in 1 quarter. The position peaked at $6K in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • First New York Securities reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • First New York Securities sold 3,200 THERAGENICS CORP shares in Q4 2013, an estimated $6K.
  • First New York Securities first reported a position in THERAGENICS CORP in Q3 2013 and held it in 1 quarter.
  • First New York Securities's THERAGENICS CORP position peaked at $6K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on First New York Securities's 13F filing for Q4 2013, filed 12 Feb 2014.